The Exchange has received the revised disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Catalyst Trusteeship Ltd

CL/SAST/26-27/00785 Date: July 30, 2026 1) National Stock Exchange of India Limited Exchange Plaza, Bandra Kurla Complex, Bandra (East), Mumbai – 400051. 2) BSE Limited Floor 25, P. J. Towers, Dalal Street, Mumbai, Mumbai – 400001. 3) Jupiter Life Line Hospitals Limited 1004, 10th Floor, 360 Degree Business Park Maharana Pratap Chowk LBS Marg, Mumbai City, Mulund West, Maharashtra, India, 400080 Dear Sir / Madam, Sub.: Rectification of Disclosure under Regulation 29(2) of SEBI (SAST) Regulations, 2011 Dear Sir/Madam, With reference to the disclosure submitted by us on 28.07.2026 (Annexure 1) under Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, we wish to inform you that the percentage of pledged holding was inadvertently mentioned as 30.67% instead of the correct percentage of 5.11%. The error was inadvertent and has occurred while considering the effect of the subdivision of equity shares of the Company from face value of ₹10 each to ₹2 each. The number of pledged shares has changed due to the stock split; however, there is no change in the actual percentage of pledged holding, which continues to remain at 5.11%. Accordingly, we are submitting the revised disclosure with the correct details for your records. We request you to kindly take the revised disclosure on record. Sincerely, For Catalyst Trusteeship Limited Authorised Signatory Name: Deesha Srikkanth Designation: Senior Vice President Place: Mumbai Encl.: As above ANNEXURE A Format for disclosures under Regulation 29(2) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 1 Name of the Target Company (TC) Jupiter Life Line Hospitals Limited Name(s) of the acquirer and Persons Acting in Catalyst Trusteeship Limited acting as Debenture Concert (PAC) with the acquirer Trustee on behalf of Debenture holders Whether the acquirer belongs to 3 No Promoter/Promoter group Name(s) of the Stock Exchange(s) where the BSE Limited and National Stock Exchange of shares of TC are Listed India Limited % w.r.t. total % w.r.t. total share/voting diluted 5 Details of the acquisition/disposal as follows Number capital share/voting wherever capital of applicable (*) the TC (**) Before the acquisition under consideration, holding of: a) Shares carrying voting rights - - - b) Shares in the nature of encumbrance 33,51,950 5.11 5.11 (pledge/lien/non-disposal undertaking/others) c) Voting rights (VR) otherwise than by shares - - - d) Warrants/convertible securities/any other - - - instrument that entitles the acquirer to receive shares carrying voting rights in the TC (specify holding in each category) e) Total (a+b+c+d) 33,51,950*** 5.11*** 5.11*** Details of acquisition / sale a) Shares carrying voting rights acquired / sold - - - b) VRs acquired / sold otherwise than by shares - - - c) Warrants/convertible securities/any other - - - instrument that entitles the acquirer to receive shares carrying voting rights in the TC (specify holding in each category) acquired / sold d) Shares Pledged/ encumbered/ invoked/ 5.11*** 5.11*** released by the acquirer 1,67,59,750*** e) Total (a+b+c+/-d) 1,67,59,750 5.11 5.11 After the acquisition/sale, holding of: a) Shares carrying voting rights - - - b) Shares encumbered with the acquirer (pledge) 1,67,59,750 5.11 5.11 c) VRs otherwise than by shares - - - d) Warrants/convertible securities/any other instrument that entitles the acquirer to receive - - - shares carrying voting rights in the TC (specify holding in each category) after acquisition e) Total (a+b+c+d) 5.11*** 5.11*** 1,67,59,750*** Mode of acquisition / disposal / sale (e.g. open Effect of the subdivision/split of equity shares market / off market/ public issue/ rights issue/ of the Company from face value of ₹10 each preferential allotment / inter-se transfer, etc.) to ₹2 each Date of acquisition/ disposal / sale of shares /VR or date of receipt of intimation of allotment July 25, 2026 of shares, whichever is applicable. Rs. 65,56,60,220 (32,78,30,110 Equity shares Equity share capital/total voting capital of the having face value of Rs 2 each) TC before the said acquisition/ disposal/ sale Rs. 65,56,60,220 (32,78,30,110 Equity shares Equity share capital/ total voting capital of the having face value of Rs 2 each) TC after the said acquisition/ disposal/ sale Total diluted share/voting capital of the TC Not Applicable after the said acquisition/ disposal Note: (*) Total share capital/voting capital to be taken as per the latest filing done by the company to the Stock Exchange under Clause 35 of the listing Agreement. (**) Diluted share/voting capital means the total number of shares in the TC assuming full conversion of the outstanding convertible securities/warrants into equity shares of the TC. (***) overall holding post slit is revised from 33,51,950 to 1,67,59,750. Signature of the acquirer / seller / Authorised Signatory For Catalyst Trusteeship Limited Authorised Signatory Name: Deesha Srikkanth Designation: Senior Vice President Place: Mumbai Date: July 30, 2026